ImClone Investigational Site

Cincinnati, Ohio 45267

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Colon Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Rectal Cancer

Studies at this site

• Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients — Completed
• A Study of Ramucirumab or Icrucumab in Colorectal Cancer — Completed
• A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed